CC
TMO icon

Centiva Capital’s Thermo Fisher Scientific TMO Stock Holding History

Centiva Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,505
Closed -$5.88M – 1844
2025
Q2 		$5.88M Buy
14,505
+3,150
+28% +$1.32M 0.1% 128
2025
Q1 		$5.65M Buy
11,355
+5,109
+82% +$2.77M 0.17% 56
2024
Q4 		$3.25M Sell
6,246
-4,293
-41% -$2.36M 0.07% 158
2024
Q3 		$6.52M Sell
10,539
-13,855
-57% -$8.2M 0.13% 133
2024
Q2 		$13.5M Buy
24,394
+22,287
+1,058% +$12.8M 0.23% 50
2024
Q1 		$1.22M Buy
+2,107
New +$1.18M 0.03% 560
2023
Q4 		– Sell
-8,672
Closed -$4.2M – 2251
2023
Q3 		$4.39M Sell
8,672
-9,554
-52% -$5.09M 0.1% 186
2023
Q2 		$9.51M Buy
+18,226
New +$9.84M 0.21% 77
2023
Q1 		– Sell
-1,191
Closed -$656K – 1844
2022
Q4 		$656K Buy
1,191
+973
+446% +$516K 0.02% 690
2022
Q3 		$111K Sell
218
-875
-80% -$490K ﹤0.01% 1274
2022
Q2 		$594K Sell
1,093
-3,165
-74% -$1.74M 0.01% 846
2022
Q1 		$2.52M Buy
4,258
+120
+3% +$68.9K 0.05% 356
2021
Q4 		$2.76M Buy
4,138
+3,650
+748% +$2.28M 0.06% 290
2021
Q3 		$279K Sell
488
-424
-46% -$233K 0.02% 810
2021
Q2 		$460K Buy
+912
New +$430K 0.01% 868
2020
Q4 		– Sell
-2,851
Closed -$1.26M – 1105
2020
Q3 		$1.26M Buy
2,851
+571
+25% +$236K 0.08% 169
2020
Q2 		$826K Buy
2,280
+1,683
+282% +$564K 0.05% 206
2020
Q1 		$169K Sell
597
-1,009
-63% -$318K 0.01% 455
2019
Q4 		$522K Buy
+1,606
New +$487K 0.03% 416

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Centiva Capital's TMO Position: Q3 2025 in Review

Centiva Capital sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 14,505 shares — an estimated $5.88M sold.

Centiva Capital first reported a position in TMO in Q4 2019 and held it in 19 quarters. The position peaked at $13.5M in Q2 2024. 2,514 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Centiva Capital reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 14,505 Thermo Fisher Scientific shares in Q3 2025, an estimated $5.88M.
  • Centiva Capital first reported a position in Thermo Fisher Scientific in Q4 2019 and held it in 19 quarters.
  • Centiva Capital's Thermo Fisher Scientific position peaked at $13.5M in Q2 2024.
  • 2,514 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.